Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2002-5-30
pubmed:abstractText
The synthesis and biological activities of a series of N-substituted cis-4a,5,6,7,8,8a-hexa- and cis-4a,5,8,8a-tetrahydro-2H-phthalazin-1-ones are described. It was found that compounds bearing a cycloalkyl group at the 2-position exhibit the highest PDE4 inhibitory activities (pIC(50) = 8.6-9.4). The N-cycloheptyl- and N-adamantanyltetrahydrophthalazinones (7h, 8, 10, 11) show high in vivo antiinflammatory activities after oral application. Additionally, some phthalazinones were found to exhibit potent suppression of LPS-induced TNFalpha release and show moderate potency against fMLP-stimulated production of ROS.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/3',5'-Cyclic-AMP Phosphodiesterases, http://linkedlifedata.com/resource/pubmed/chemical/Adamantane, http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents..., http://linkedlifedata.com/resource/pubmed/chemical/Cyclic Nucleotide..., http://linkedlifedata.com/resource/pubmed/chemical/Cyclic Nucleotide..., http://linkedlifedata.com/resource/pubmed/chemical/Cycloheptanes, http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Lipopolysaccharides, http://linkedlifedata.com/resource/pubmed/chemical/Phthalazines, http://linkedlifedata.com/resource/pubmed/chemical/Reactive Oxygen Species, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0022-2623
pubmed:author
pubmed:issnType
Print
pubmed:day
6
pubmed:volume
45
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2520-5
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:12036360-3',5'-Cyclic-AMP Phosphodiesterases, pubmed-meshheading:12036360-Adamantane, pubmed-meshheading:12036360-Administration, Oral, pubmed-meshheading:12036360-Animals, pubmed-meshheading:12036360-Anti-Inflammatory Agents, Non-Steroidal, pubmed-meshheading:12036360-Cyclic Nucleotide Phosphodiesterases, Type 3, pubmed-meshheading:12036360-Cyclic Nucleotide Phosphodiesterases, Type 4, pubmed-meshheading:12036360-Cycloheptanes, pubmed-meshheading:12036360-Edema, pubmed-meshheading:12036360-Enzyme Inhibitors, pubmed-meshheading:12036360-Female, pubmed-meshheading:12036360-Humans, pubmed-meshheading:12036360-Leukocytes, Mononuclear, pubmed-meshheading:12036360-Lipopolysaccharides, pubmed-meshheading:12036360-Luminescent Measurements, pubmed-meshheading:12036360-Mice, pubmed-meshheading:12036360-Phthalazines, pubmed-meshheading:12036360-Reactive Oxygen Species, pubmed-meshheading:12036360-Structure-Activity Relationship, pubmed-meshheading:12036360-Tumor Necrosis Factor-alpha
pubmed:year
2002
pubmed:articleTitle
Novel selective PDE4 inhibitors. 3. In vivo antiinflammatory activity of a new series of N-substituted cis-tetra- and cis-hexahydrophthalazinones.
pubmed:affiliation
Leiden/Amsterdam Center for Drug Research, Division of Medicinal Chemistry, Department of Pharmacochemistry, Vrije Universiteit, De Boelelaan 1085c, 1081 HV Amsterdam, The Netherlands. mmeij@rnc.vu.nl
pubmed:publicationType
Journal Article, In Vitro